Haghdoost, M.; Young, S.; Roberts, M.; Krebs, C.; Bonn-Miller, M.O.
Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist. Biomedicines 2024, 12, 1551.
https://doi.org/10.3390/biomedicines12071551
AMA Style
Haghdoost M, Young S, Roberts M, Krebs C, Bonn-Miller MO.
Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist. Biomedicines. 2024; 12(7):1551.
https://doi.org/10.3390/biomedicines12071551
Chicago/Turabian Style
Haghdoost, Mehdi, Scott Young, Matthew Roberts, Caitlyn Krebs, and Marcel O. Bonn-Miller.
2024. "Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist" Biomedicines 12, no. 7: 1551.
https://doi.org/10.3390/biomedicines12071551
APA Style
Haghdoost, M., Young, S., Roberts, M., Krebs, C., & Bonn-Miller, M. O.
(2024). Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist. Biomedicines, 12(7), 1551.
https://doi.org/10.3390/biomedicines12071551